Global Duchenne Muscular Dystrophy Drugs Market Set to Reach $ 5.5 Billion by 2032, With a CAGR of 10.17% Driven by New Product Approvals, Launches, and a Favorable Landscape Dublin, April 29, 2024 (GLOBE NEWSWIRE) -- The "Global Duchenne Muscular Dystrophy Drugs Market by Product Type, Therapeutic Approach, End User, and Region 2024-2032" report has been added to ...

Global $111+ Billion Duchenne Muscular Dystrophy (DMD) Drugs Market Analysis 2024-2034 - Rapid Growth in Exon-Skipping Therapies Reflects Precision Medical Interventions Fueled by R&D Dublin, March 11, 2024 (GLOBE NEWSWIRE) -- The "Global Duchenne Muscular Dystrophy Drugs Market by Drug Type, by Distribution Channel, and By Region" report has been added to ...

Gene Therapy Revolutionizes Duchenne Muscular Dystrophy Treatment, Driving Global Market Growth Dublin, Oct. 20, 2023 (GLOBE NEWSWIRE) -- The "Duchenne Muscular Dystrophy Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market...

Global Duchenne Muscular Dystrophy Drugs Business Report 2023: Market to Reach $18.1 Billion by 2030, Growing at a Staggering CAGR of 42.5% Dublin, Jan. 26, 2023 (GLOBE NEWSWIRE) -- The "Duchenne Muscular Dystrophy Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Duchenne...

United States Duchenne Muscular Dystrophy Market Report 2020 - Pipeline, Epidemiology, Key Products, Market Valuations & Forecast, Drugs Sales and Market Shares Dublin, Sept. 04, 2020 (GLOBE NEWSWIRE) -- The "US Duchenne Muscular Dystrophy Market and Competitive Landscape - 2020" report has been added to ResearchAndMarkets.com's offering. The report...